{"id":"NCT00059332","sponsor":"Jeffrey L. Saver","briefTitle":"Field Administration of Stroke Therapy - Magnesium (FAST-MAG) Trial","officialTitle":"Field Administration of Stroke Therapy-Magnesium Trial: A Randomized, Double-Blind, Placebo Controlled Trial of Neuroprotective Magnesium Sulfate Therapy for Acute Stroke Initiated Within 2 Hours of Onset by Paramedics in the Field","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2013-03","completion":"2013-03","firstPosted":"2003-04-24","resultsPosted":"2015-08-21","lastUpdate":"2015-08-21"},"enrollment":1700,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Cerebrovascular Accident"],"interventions":[{"type":"DRUG","name":"Magnesium Sulfate","otherNames":["MA 135 magnesium sulfate heptahydrate"]},{"type":"DRUG","name":"Normal Saline","otherNames":["SO155 sodium chloride"]}],"arms":[{"label":"Magnesium Sulfate","type":"EXPERIMENTAL"},{"label":"Normal saline","type":"PLACEBO_COMPARATOR"}],"summary":"The goal of this study is to evaluate the effectiveness and safety of field-initiated magnesium sulfate in improving the long-term functional outcome of patients with acute stroke.","primaryOutcome":{"measure":"Modified Rankin Scale","timeFrame":"3 months after stroke onset","effectByArm":[{"arm":"Normal Saline","deltaMin":2,"sd":null},{"arm":"Magnesium Sulfate","deltaMin":2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.28"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["39011360","38126183","36878722","36599321","35380053","32038463","31955642","30039165","29301973","28389617","27679533","26658446","26265130","25651247"],"seeAlso":["http://www.fastmag.info"]},"adverseEventsSummary":{"seriousAny":{"events":422,"n":843},"commonTop":["Hypokalaemia","Headache","Urinary tract infection"]}}